Inui Takashi, Ohkubo Tadayasu, Emi Maiko, Irikura Daisuke, Hayaishi Osamu, Urade Yoshihiro
Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation and Department of Molecular Behavioral Biology, Osaka Bioscience Institute, 6-2-4 Furuedai, Suita, Osaka 565-0874, Japan.
J Biol Chem. 2003 Jan 31;278(5):2845-52. doi: 10.1074/jbc.M209934200. Epub 2002 Nov 18.
We found that low concentrations of guanidine hydrochloride (GdnHCl, <0.75 M) or urea (<1.5 M) enhanced the enzyme activity of lipocalin-type prostaglandin (PG) D synthase (L-PGDS) maximally 2.5- and 1.6-fold at 0.5 M GdnHCl and 1 M urea, respectively. The catalytic constants in the absence of denaturant and in the presence of 0.5 M GdnHCl or 1 m urea were 22, 57, and 30 min(-1), respectively, and the K(m) values for the substrate, PGH(2), were 2.8, 8.3, and 2.3 microm, respectively, suggesting that the increase in the catalytic constant was mainly responsible for the activation of L-PGDS. The intensity of the circular dichroism (CD) spectrum at 218 nm, reflecting the beta-sheet content, was also increased by either denaturant in a concentration-dependent manner, with the maximum at 0.5 M GdnHCl or 1 M urea. By plotting the enzyme activities against the ellipticities at 218 nm of the CD spectra of L-PGDS in the presence or absence of GdnHCl or urea, we found two states in the reversible folding process of L-PGDS: one is an activity-enhanced state and the other, an inactive state. The NMR analysis of L-PGDS revealed that the hydrogen-bond network was reorganized to be increased in the activity-enhanced state formed in the presence of 0.5 M GdnHCl or 1 m urea and to be decreased but still remain in the inactive intermediate observed in the presence of 2 M GdnHCl or 4 M urea. Furthermore, binding of the nonsubstrate ligands, bilirubin or 13-cis-retinal, to L-PGDS changed from a multistate mode in the native form of L-PGDS to a simple two-state mode in the activity-enhanced form, as monitored by CD spectra of the bound ligands. Therefore, L-PGDS is a unique protein whose enzyme activity and ligand-binding property are biphasically altered during the unfolding process by denaturants.
我们发现,低浓度的盐酸胍(GdnHCl,<0.75 M)或尿素(<1.5 M)可增强脂钙蛋白型前列腺素(PG)D合成酶(L-PGDS)的酶活性,在0.5 M GdnHCl和1 M尿素条件下,酶活性分别最大提高2.5倍和1.6倍。在不存在变性剂以及存在0.5 M GdnHCl或1 M尿素的情况下,催化常数分别为22、57和30 min⁻¹,底物PGH₂的Kₘ值分别为2.8、8.3和2.3 μM,这表明催化常数的增加是L-PGDS激活的主要原因。反映β-折叠含量的218 nm处圆二色性(CD)光谱强度也随变性剂浓度的增加而增加,在0.5 M GdnHCl或1 M尿素时达到最大值。通过绘制L-PGDS在有或无GdnHCl或尿素存在时的酶活性与218 nm处CD光谱椭圆率的关系图,我们发现在L-PGDS的可逆折叠过程中有两种状态:一种是活性增强状态,另一种是无活性状态。L-PGDS的核磁共振分析表明,氢键网络在0.5 M GdnHCl或1 M尿素存在下形成的活性增强状态中发生重组并增加,而在2 M GdnHCl或4 M尿素存在下观察到的无活性中间体中则减少但仍然存在。此外,通过结合配体的CD光谱监测,非底物配体胆红素或13-顺式视黄醛与L-PGDS的结合从L-PGDS天然形式的多态模式转变为活性增强形式的简单二态模式。因此,L-PGDS是一种独特的蛋白质,其酶活性和配体结合特性在变性剂诱导的解折叠过程中呈双相变化。